TxCell Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | TxCell

TxCell S.A. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Gestys Santé Biotech

125,000

0.54%

9.6%

03/23/2018

Arcalis

5,640

0.02%

2,051

12/31/2015

GFS Aktien Anlage Global

4,300

0.02%

0.06%

09/30/2017

Aviva Investors Investment Funds ICVC - European Equity Fund

-32,468

10/15/2017

View Profile

Address	Les Cardoulines HT1 Valbonne-Sophia Antipolis Rhone-Alpes 06560 France
Employees	-
Website	http://www.txcell.com/index.php/fr
Updated	09/14/2018
TxCell SA is a biotechnology company. The company engages in the research and development of cellular immunotherapy for chronic inflammatory and autoimmune diseases. Its pipeline consists of Ovasave, col treg, lupus, transplantation and car treg dermatology.